Athyrium Capital Management Mergers and Acquisitions Summary

Asset Manager Profile

In the last 3 years, Athyrium Capital Management has acquired 1 company. It has also invested in 4 others.

Athyrium Capital Management’s most common sectors for investment arelife science (50%) and healthcare services (21%) . The Firm’s most common investment types include stake purchase (30%) and growth capital (23%). In total, Athyrium Capital Management has invested in 17 US states and 6 different countries. Its largest (disclosed) acquisition occurred in 2016 when it acquired Team Health Holdings for $6.1B.

In the last 3 years, Athyrium Capital Management has exited 5 companies. The Firm’s most common exit type is ipo (34%). Athyrium Capital Management’s largest (disclosed) exit occurred in 2015 when it sold Ikaria for $2.3B.

Join Mergr to view Athyrium Capital Management’s full profile and discover more large asset manager investors just like it.

M&A Summary

  • M&A Total Activity53
    • M&A Buy Activity44
    • M&A Sell Activity9
  • Total Sectors Invested 7
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 28
  • M&A Advisors 4

Athyrium Capital Management LP

505 Fifth Avenue, 18th Floor,
New York, New York 10017
United States
(212) 402-6925
www.athyrium.com
info@athyrium.com

Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York City.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Stake Purchase

Geographic Preferences: East US, Midwest US, South US, West US, United Kingdom, Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 25 150
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.4/yr) # 37 2 3 2 - - 44
vol $12.6B $12.6B
Sell (1.4/yr) # 2 2 3 - 1 1 9
vol $2.4B $2.4B
  53

Most Recent M&A

Company Date Value Type
Alcresta Therapeutics, Inc. 2024-03-12 - Secondary Sale
Newton, Massachusetts · www.alcresta.com
Lannett Company, Inc. 2023-05-04 - Bankruptcy
Trevose, Pennsylvania · www.lannett.com
Basilea Pharmaceutica Ltd. 2022-09-07 - Stake Purchase
Allschwil, Switzerland · www.basilea.com
uMotif Ltd. 2022-05-25 - Growth Capital
London, United Kingdom · www.umotif.com
Oui Therapeutics, Inc. 2021-12-01 - Venture
New Haven, Connecticut · www.ouitherapeutics.com
InnovaCare Health Solutions LLC 2021-11-19 - Secondary Sale
Orlando, Florida · www.innovacarehealth.com
Summit Behavioral Healthcare LLC 2021-09-09 - Secondary Buyout
Franklin, Tennessee · www.summitbhc.com
Puma Biotechnology, Inc. 2021-07-26 - Stake Purchase
Los Angeles, California · www.pumabiotechnology.com
Valneva SE 2021-05-06 - IPO
Saint-Herblain, France · www.valneva.com
Clover Health Investments Corp. 2021-01-08 - IPO
Franklin, Tennessee · www.cloverhealth.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Team Health Holdings, Inc. 2016-10-31 Team Health - VirtualCare 2024-09-17 1
Knoxville, Tennessee · www.teamhealth.com , United States
ArisGlobal LLC 2019-06-16 Boehringer Ingelheim's Benefit-Risk Analytic System (BRASS) 2022-05-11 2
Waltham, Massachusetts · www.arisglobal.com Ingelheim am Rhein, Germany
Upstream Rehabilitation, Inc. 2015-12-15 Results Physiotherapy 2021-08-02 4
Birmingham, Alabama · www.urpt.com Nashville, Tennessee · www.resultspt.com
Clario 2016-03-08 BioClinica, Inc. 2020-12-10 6
Philadelphia, Pennsylvania · www.clario.com Princeton, New Jersey · www.bioclinica.com
Alvogen, Inc. 2015-06-23 Assertio Therapeutics, Inc. - Gralise Business 2020-01-13 4
Morristown, New Jersey · www.alvogen.com Newark, California
Alvogen, Inc. 2015-06-23 Alvogen CEE 2019-10-25 1
Morristown, New Jersey · www.alvogen.com , Poland
TEAM Services Group 2015-04-20 Ameribest Home Care, Inc. 2019-09-20 3
San Diego, California · www.teamsvc.com Philadelphia, Pennsylvania · www.ameribesthomecare.com
PharMerica Corp. 2017-08-02 BrightSpring Health Services, Inc. 2018-12-11 2
Louisville, Kentucky · www.pharmerica.com Louisville, Kentucky · www.brightspringhealth.com
Elara Caring 2018-04-10 Jordan Health Services 2018-04-10 5
Dallas, Texas · www.elara.com Addison, Texas · www.jhsi.com
Elara Caring 2018-04-10 Great Lakes Home Health Services, Inc. 2018-04-10 4
Dallas, Texas · www.elara.com Jackson, Michigan · www.greatlakescaring.com

M&A by Sector

Sector Current # Value All-time # Value
Life Science 17 (49%) 3.4B (31%) 22 (50%) 5.0B (40%)
Healthcare Services 7 (20%) 1.5B (13%) 9 (20%) 1.5B (12%)
Medical Products 5 (14%) - 6 (14%) -
Consumer Services 3 (9%) - 3 (7%) -
Software 2 (6%) - 2 (5%) -
Staffing 1 (3%) 6.1B (56%) 1 (2%) 6.1B (49%)
Consumer Products - - 1 (2%) -
Total 35 $11.0B 44 $12.6B

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 31 (89%) 11.0B (100%) 39 (89%) 12.6B (100%)
  California 5 (14%) - 8 (18%) -
  Pennsylvania 3 (9%) - 4 (9%) -
  Massachusetts 3 (9%) - 4 (9%) -
  Illinois 3 (9%) 1.5B (13%) 3 (7%) 1.5B (12%)
  Tennessee 2 (6%) 6.1B (56%) 3 (7%) 6.1B (49%)
  New Jersey 2 (6%) 2.0B (18%) 3 (7%) 3.6B (29%)
  Florida 2 (6%) - 3 (7%) -
  Kentucky 2 (6%) 1.4B (13%) 2 (5%) 1.4B (11%)
  Connecticut 1 (3%) - 1 (2%) -
  Alabama 1 (3%) - 1 (2%) -
  Washington 1 (3%) - 1 (2%) -
  Virginia 1 (3%) - 1 (2%) -
  Texas 1 (3%) - 1 (2%) -
  North Carolina 1 (3%) - 1 (2%) -
  New York 1 (3%) - 1 (2%) -
  Nevada 1 (3%) - 1 (2%) -
  Maryland 1 (3%) - 1 (2%) -
United Kingdom 1 (3%) - 1 (2%) -
Australia 1 (3%) - 1 (2%) -
Denmark 1 (3%) - 1 (2%) -
Switzerland 1 (3%) - 1 (2%) -
Ireland - - 1 (2%) -
Total 35 $11.0B 44 $12.6B

Acquisitions by Deal Type

Type Current # Value All-time # Value
Stake Purchase 11 (31%) - 13 (30%) -
Growth Capital 9 (26%) - 10 (23%) -
Secondary Buyout 6 (17%) 3.5B (32%) 6 (14%) 3.5B (27%)
Venture 1 (3%) - 5 (11%) -
Buyout (LBO, MBO, MBI) 2 (6%) - 4 (9%) 1.6B (13%)
PIPE 3 (9%) - 3 (7%) -
Going Private 2 (6%) 7.5B (68%) 2 (5%) 7.5B (60%)
Consolidation 1 (3%) - 1 (2%) -
Total 35 $11.0B 44 $12.6B

Exits by Deal Type

Type Total # Value
IPO 3 (33%) -
Trade Sale - Public Company 2 (22%) 2.4B (100%)
Secondary Sale 2 (22%) -
Bankruptcy 1 (11%) -
Merger 1 (11%) -
Total 9 $2.4B

Top M&A Advisors

Financial Deals
Rothschild Global Advisory
 1
Legal Deals
Advokatfirmaet Thommessen AS
 1
Ropes & Gray
 1
Covington & Burling
 1

Deal Values

buy # Total
> $1B 5 $12.6B
TOTAL $12.6B
Largest Team Health Holdings, Inc.
$6.1B (2016-10-31)
sell # Total
> $1B 1 $2.3B
< $100M 1 $62M
TOTAL $2.4B
Largest Ikaria, Inc.
$2.3B (2015-04-16)

M&A Connections

Deals
Acquired from
Investor(s)
14%
6 (14%)
Exited to
Investor(s)
22%
2 (22%)
Strategic(s)
33%
3 (33%)

Investor Summary

Investor Type

Asset Manager

Size

Large

PE Assets

3.7B USD

Established

2008

Specialist/Generalist

Specialist

Leadership

Jeffrey Ferrell

Managing Partner

Hondo Sen

Partner

Jeremy Lack

Partner

Laurent Hermouet

Partner

Uttam Jain

Partner

FAQ

When was Athyrium Capital Management LP founded?

Athyrium Capital Management LP was founded in 2008.

What type of investor is Athyrium Capital Management LP?

Athyrium Capital Management LP is an asset manager.

Where is Athyrium Capital Management LP headquartered?

Athyrium Capital Management LP is headquartered in New York, New York.

How much capital does Athyrium Capital Management LP have under management?

Athyrium Capital Management LP has 3.7B USD under management.

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal